|
|
|
Genetic vaccine for metastatic breast cancer shows promise in mice studies
Scientists at the University of Nebraska Medical Center have developed a genetic vaccine for metastatic breast cancer and other tumors, which shows great promise in early studies in mice. The vaccine uses a combination of components that are being used in existing clinical trials for other diseases. The vaccine combines DNA and adenovirus gene delivery mechanisms. Together, the combination can deliver the p53 gene as a vaccine for breast cancer. Contact:
Tom O'Connor
toconnor@unmc.edu
402-559-4690
University of Nebraska Medical Center
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|